Post Inflammatory Hyperpigmentation, or PIH for short, is a common skin condition that affects millions of people worldwide. It's characterized by dark patches on the skin that develop after an injury, inflammation, or acne breakout. While it doesn't pose any serious health risks, PIH can be frustrating and embarrassing for those who experience it. Fortunately, there are several effective treatments available to help diminish these unsightly marks and improve the overall appearance of your skin. So if you're a medical professional looking to understand more about post inflammatory hyperpigmentation causes and treatments - keep reading!
Post Inflammatory Hyperpigmentation (PIH) is a type of hyperpigmentation that occurs as a result of skin inflammation or injury. It's a common condition, particularly among people with darker skin tones. PIH manifests as flat, dark patches on the skin that are either brown, black or red in color.
The primary cause of PIH is an overproduction of melanin - the pigment responsible for giving our skin its color. When the body detects an injury or inflammation to the skin, it produces more melanin than usual to help protect and heal damaged cells. This excess melanin can accumulate in certain areas and create dark patches.
Some conditions that can lead to PIH include acne breakouts, eczema, psoriasis, insect bites and burns. Even something as simple as scratching your skin too hard can trigger PIH.
Post inflammatory hyperpigmentation (PIH) is a common skin condition that occurs as a result of various underlying causes. The primary cause of PIH is inflammation, which triggers an overproduction of melanin in the affected area.
One common trigger for PIH is acne, which can leave behind dark spots on the skin long after the pimples have cleared up. Other possible causes include injuries or wounds, such as cuts or burns, and certain medical conditions like eczema and psoriasis.
In some cases, medications may also contribute to post-inflammatory hyperpigmentation. Certain drugs like antimalarials and chemotherapy agents are known to increase pigmentation levels in some individuals.
Furthermore, people with darker skin tones are more likely to experience PIH due to their increased production of melanin. Hormonal changes during pregnancy or with oral contraceptive use can also lead to excess pigment production and subsequent hyperpigmentation.
Treatments for Post Inflammatory Hyperpigmentation (PIH) vary depending on the severity of the condition. Mild cases can be treated with over-the-counter creams that contain ingredients like hydroquinone, kojic acid, or retinoids which work by blocking melanin production and promoting skin cell turnover. These topical treatments are usually effective in lightening dark spots caused by PIH.
For moderate to severe cases, dermatologists may recommend more aggressive treatment options such as chemical peels, microdermabrasion or laser therapy. Chemical peels involve applying a solution containing acids to exfoliate the top layers of the skin while microdermabrasion uses tiny crystals to remove dead skin cells.
Laser therapy uses intense pulses of light to target pigmented areas which helps break up melanin clusters and stimulate collagen production resulting in improved texture and tone. However, these treatments require multiple sessions and come at a higher cost than topical creams.
Post inflammatory hyperpigmentation is a common skin condition that affects many people of all ages and skin types. It can result from various causes, including acne, eczema, psoriasis, and other medical conditions.
Fortunately, there are several treatments available for post inflammatory hyperpigmentation. These include topical creams containing hydroquinone or retinoids, chemical peels, microdermabrasion and laser therapy.
If you're experiencing post inflammatory hyperpigmentation or any other skin concerns, consult with a dermatologist who can help determine the best treatment plan for your individual needs. With proper care and treatment, you can achieve clear and healthy-looking skin once again.
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
How artificial intelligence could significantly improve the prognosis for cancer patients.
3.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
4.
Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
2.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
3.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
4.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
5.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation